Baricitinib Liposomes as a New Approach for the Treatment of Sjögren's Syndrome

• المؤلفون الرئيسيون: Núria Garrós (مؤلف), Mireia Mallandrich (مؤلف), Negar Beirampour (مؤلف), Roya Mohammadi (مؤلف), Òscar Domènech (مؤلف), Maria José Rodríguez-Lagunas (مؤلف), Beatriz Clares (مؤلف), Helena Colom (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2022-09-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Sjögren's syndrome is a chronic systemic autoimmune disease affecting from 0.2 to 3% of the general population. The current treatment for Sjögren's syndrome is aimed at controlling symptoms such as dry eyes and xerostomia. Systemic therapy with glucocorticoids or immunosuppressants is also...